A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria

Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8-aminoquinoline drugs are crucial for the complete removal of the parasite from the human host (radical cure). While we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadhewa, Arkasha, Cassidy-Seyoum, Sarah, Acharya, Sanjaya, Devine, Angela, Price, Ric N., Mwaura, Muthoni, Thriemer, Kamala, Ley, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220632/
https://www.ncbi.nlm.nih.gov/pubmed/37242320
http://dx.doi.org/10.3390/pathogens12050650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220632/
https://www.ncbi.nlm.nih.gov/pubmed/37242320
http://dx.doi.org/10.3390/pathogens12050650

Ejemplares similares